GO
Loading...

Enter multiple symbols separated by commas

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Wednesday, 29 Apr 2015 | 6:14 PM ET

    Baxter International Inc. fell$. 48 or. 7 percent, to $69.75. Bristol-Myers Squibb Co. fell$. 25 or. 4 percent, to $64.29. Eli Lilly& Co. rose $1.10 or 1.5 percent, to $72.28.

  • Midday Glance: Pharmaceuticals companies Wednesday, 29 Apr 2015 | 2:53 PM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $69.74. Bristol-Myers Squibb Co. fell$. 56 or. 9 percent, to $63.98. Eli Lilly& Co. rose$. 97 or 1.4 percent, to $72.15.

  • Early Glance: Pharmaceuticals companies Wednesday, 29 Apr 2015 | 10:45 AM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $69.92. Bristol-Myers Squibb Co. rose$. 19 or. 3 percent, to $64.73. Eli Lilly& Co. rose $1.00 or 1.4 percent, to $72.18.

  • TOKYO— Japan's largest drugmaker Takeda Pharmaceutical Co. said Wednesday it has agreed to pay up to $2.4 billion to thousands of patients and their families over its diabetes drug Actos which has been linked to cancer. The settlement will go into effect if 95 percent of the litigants agree to the deal, and the company would pay $2.37 billion.

  • Takeda to take $2.7 bln charge to settle Actos cases Tuesday, 28 Apr 2015 | 8:31 PM ET

    April 28- Takeda Pharmaceutical Co Ltd and its Takeda Pharmaceuticals U.S.A. Inc unit said on Tuesday they reached a $2.4 billion agreement to settle the majority of claims involving the diabetes drug Actos. Takeda said it will take a $2.7 billion charge against earnings to cover the settlement costs in the 2014 fiscal fourth quarter ended March 31.

  • Final Glance: Pharmaceuticals companies Tuesday, 28 Apr 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 14 or. 2 percent, to $70.23. Bristol-Myers Squibb Co. fell$. 62 or 1.0 percent, to $64.54. Eli Lilly& Co. rose$. 29 or. 4 percent, to $71.18.

  • Midday Glance: Pharmaceuticals companies Tuesday, 28 Apr 2015 | 1:50 PM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $70.24. Bristol-Myers Squibb Co. fell$. 87 or 1.3 percent, to $64.29. Eli Lilly& Co. rose$. 29 or. 4 percent, to $71.18.

  • Early Glance: Pharmaceuticals companies Tuesday, 28 Apr 2015 | 10:39 AM ET

    Baxter International Inc. fell$. 48 or. 7 percent, to $69.89. Bristol-Myers Squibb Co. fell $1.39 or 2.1 percent, to $63.77. Eli Lilly& Co. fell$. 20 or. 3 percent, to $70.70.

  • Final Glance: Pharmaceuticals companies Monday, 27 Apr 2015 | 6:06 PM ET

    Baxter International Inc. fell$. 77 or 1.1 percent, to $70.37. Bristol-Myers Squibb Co. fell$. 64 or 1.0 percent, to $65.16. Johnson& Johnson fell$. 50 or. 5 percent, to $100.58.

  • Midday Glance: Pharmaceuticals companies Monday, 27 Apr 2015 | 1:50 PM ET

    Baxter International Inc. fell$. 46 or. 6 percent, to $70.68. Bristol-Myers Squibb Co. fell$. 55 or. 8 percent, to $65.25. Eli Lilly& Co. fell$. 61 or. 9 percent, to $70.97.

  • Early Glance: Pharmaceuticals companies Monday, 27 Apr 2015 | 11:25 AM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $71.29. Bristol-Myers Squibb Co. rose$. 16 or. 2 percent, to $65.96. Eli Lilly& Co. rose$. 09 or. 1 percent, to $71.67.

  • Final Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 8:08 PM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $71.14. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $65.80. Eli Lilly& Co. fell$. 82 or 1.1 percent, to $71.58.

  • Midday Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $71.12. Bristol-Myers Squibb Co. fell$. 28 or. 4 percent, to $65.72. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.42.

  • Early Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 10:55 AM ET

    Baxter International Inc. fell$. 42 or. 6 percent, to $71.09. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $65.89. Pfizer fell$. 11 or. 3 percent, to $35.25.

  • Final Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 6:05 PM ET

    Baxter International Inc. rose $1.13 or 1.6 percent, to $71.51. Bristol-Myers Squibb Co. fell$. 60 or. 9 percent, to $66.00. Eli Lilly& Co. rose$. 10 or. 1 percent, to $72.40.

  • Midday Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 1:24 PM ET

    Baxter International Inc. rose $1.67 or 2.4 percent, to $72.05. Bristol-Myers Squibb Co. fell$. 54 or. 8 percent, to $66.06. Eli Lilly& Co. rose$. 25 or. 3 percent, to $72.55.

  • Early Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 11:02 AM ET

    Baxter International Inc. rose $1.00 or 1.4 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 63 or. 9 percent, to $65.97. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.32.

  • April 23- A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells. The partnership between AstraZeneca's research and development arm MedImmune and Juno is the latest collaboration between companies intent on developing a new class of drugs known as...

  • April 23- Eli Lilly and Co soundly beat quarterly profit estimates on lower-than-expected spending on research and marketing but stuck to its full-year earnings forecast while revenue fell but matched expectations. Lilly earned $530 million, or 50 cents per share, in the quarter, compared with $728 million, or 68 cents per share, a year earlier..

  • The Indianapolis- based drugmaker posted a net profit of $529.5 million, or 50 cents per share, for the first quarter ended March 31, compared with a profit of $727.9 million, or 68 cents per share, a year earlier. In January, the company forecast full-year adjusted earnings of $3.10- $3.20 per share, and sales of $19.50- $20 billion. Lilly on Thursday cut its full-year...